AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On June 25, 2025, Illumina's trading volume reached $343 million, marking a 61.96% increase from the previous day. This surge placed
at the 283rd position in terms of trading volume for the day. Illumina's stock price rose by 1.87%, extending its winning streak to five consecutive days, with a total gain of 4.20% over the past five days.Illumina's recent acquisition of SomaLogic is set to bolster its presence in the growing proteomics market and advance its multiomics strategy, which was announced in 2024. This strategic move is expected to enhance Illumina's capabilities in proteomics, a field that focuses on the study of proteins and their functions. The acquisition is part of Illumina's broader vision to unlock the power of genomics and proteomics, providing more comprehensive insights into biological systems.
Illumina has announced that it will acquire SomaLogic for $350 million, with an additional $75 million in milestones. The company expects SomaLogic's business to become profitable by 2027. This acquisition is a significant step in Illumina's multiomics journey, leveraging SomaLogic's deep proteomics expertise and history of collaboration with Illumina. The deal is anticipated to accelerate Illumina's proteomics business and strengthen its position in the multiomics market.
Hunt down the stocks with explosive trading volume.

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025

Dec.05 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet